107 related articles for article (PubMed ID: 6712173)
1. Antitumour action of 1,5-dihalogeno-, and 1, 2-4, 5-dianhydro-xylitol derivatives.
Jeney A; Kopper L; Lapis K; Vidra L; Institoris L
Anticancer Res; 1984; 4(1-2):23-5. PubMed ID: 6712173
[TBL] [Abstract][Full Text] [Related]
2. [Dependence of the antitumor activity of nitroso alkyl urea derivatives on their chemical structure].
Sharashidze LK; Turkiia NG; Lagidze DR; Adamiia IK; Asatiani VV
Eksp Onkol; 1989; 11(2):62-5. PubMed ID: 2737133
[TBL] [Abstract][Full Text] [Related]
3. Effect of thaliblastine on transplantable tumours in mice.
Mircheva J; Stoychkov J
Biomedicine; 1976 Sep; 25(8):280-1. PubMed ID: 137002
[TBL] [Abstract][Full Text] [Related]
4. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
[No Abstract] [Full Text] [Related]
5. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new Rh (I) complexes with sulfonamide derivatives.
Craciunescu G; Scarcia V; Furlani A; Iglesias EP; Ghirvu C; Papaioannou A
Anticancer Res; 1989; 9(3):781-5. PubMed ID: 2764523
[TBL] [Abstract][Full Text] [Related]
7. Structure-antitumour activity relationships for new platinum complexes.
Craciunescu DG; Doadrio A; Furlani A; Scarcia V
Chem Biol Interact; 1982 Nov; 42(2):153-64. PubMed ID: 6891293
[TBL] [Abstract][Full Text] [Related]
8. QSAR of acridines, III. Structure-activity relationship for antitumour imidazoacridinones and intercorrelations between in vivo and in vitro tests.
Mazerska Z; Augustin E; Dziegielewski J; Chołody MW; Konopa J
Anticancer Drug Des; 1996 Jan; 11(1):73-88. PubMed ID: 8639249
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P
Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298
[TBL] [Abstract][Full Text] [Related]
10. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
Csányi E; Halász M
Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
[No Abstract] [Full Text] [Related]
11. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
12. [Substances with antineoplastic effect. 29. N-delta-6-purinylthio valeryl-amino acids and analogous dipeptide and triglycerin derivatives].
Semonský M; Cerný A; Jelínek V
Arzneimittelforschung; 1970 Mar; 20(3):316-23. PubMed ID: 5468410
[No Abstract] [Full Text] [Related]
13. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
Zhou JX; Liang HZ; Xu B
Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
[No Abstract] [Full Text] [Related]
14. Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts.
Welchinskaya HV; Piecuszak B; Kovalenko EA; Sharykina NI; Getman KI; Podgorsky VS
Mikrobiol Z; 2003; 65(5):20-5. PubMed ID: 14723158
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and toxicological studies on new Rh(I) organometallic complexes.
Craciunescu DG; Scarcia V; Furlani A; Papaioannou A; Parrondo Iglesias E; Alonso MP
In Vivo; 1991; 5(4):329-32. PubMed ID: 1810417
[TBL] [Abstract][Full Text] [Related]
16. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
17. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
18. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
Gutsche W; Schulze W; Jungstand W; Wohlrabe K
Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of aminoacyl thiaolidones as potential antitumour agents.
Lima Leite AC; Santos LM; Barbosa FF; de Oliveira Cardoso MV; Moreira DR; de Souza IA
Biomed Pharmacother; 2006 Apr; 60(3):121-6. PubMed ID: 16545938
[TBL] [Abstract][Full Text] [Related]
20. ICRF-187 in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
